Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Immune Pharmaceuticals is 'Not Rated'. Macroaxis provides Immune Pharmaceuticals buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding IMNP positions. The advice algorithm takes into account all of Immune Pharmaceuticals available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from IMNP buy-and-hold prospective. See also Risk vs Return Analysis.
Recommendations are not available for this entity. Please try other suggestions below
We are unable to locate Immune Pharmaceuticals Advice at this time.
If you believe the indicator you are trying to look up is valid please let us know and we will check it out.